Year 1 Residency Award

Looking for the year 2 award? Click here.

Sponsored by:  

About the Award

The Pharmacy Practice Residency Award recognizes year 1 pharmacy practice residents whose major projects are judged to be most deserving in terms of significant innovation, practical application, and/or development in an institutional pharmacy practice setting. Winners receive a $1,000 cash prize.

Award Criteria

To be eligible, each candidate must:

  • Be a current member of CSHP and must have been a member of CSHP at the time the residency was completed;
  • Be currently enrolled in, or one year post-completion, of a CPRB-accredited (or accreditation-pending) year 1 pharmacy practice residency program in the province of the branch administering the award. For the 2023 award, Members from the 2021-2022 and 2022-2023 residency programs are eligible, depending on the submission deadline set by the branch; and
  • Submit an award application to the branch in the province in which the residency was completed. The residency project manuscript must be formatted according to the Canadian Journal of Hospital Pharmacy's (CJHP) Author Guidelines.

Winners of the 2022 award may not apply for the 2023 award.

Application Process

Each branch will be entitled to one Pharmacy Practice Residency Award for every 10 pharmacy residents who are CSHP Members and who are enrolled in a CPRB-accredited (or accreditation-pending) program in the province. All participating branches advertise and administer the program annually within their respective branches. The branches also adjudicate the award submissions and present the awards at branch award presentations.

Check your branch website for submission requirements and deadlines.

Inquiries should be directed to:
Debi Allen
, CPRB Coordinator,
Direct: (613) 909-9962

    Winners of the 2023 Pharmacy Practice Residency Award, sponsored by Pfizer Canada

    British Columbia Branch (5 awards)

    1. Kathleen Lau (Lower Mainland Pharmacy Services)

    • The Effect of Infographic Counselling Aid on Patient Treatment Satisfaction and Understanding in Heart Failure with Reduced Ejection Fraction (INFOSat-HF): A Prospective Single- Arm Before-and-After Study 

    2. Amy Jradi (Northern Health)

    • Pharmacists’ Perceived Confidence and Efficacy in Managing Patients with Suicidal Ideation-An Assessment of a Pilot Workshop 

    3. Zoe Hopkins  (Island Health)

    • A Retrospective Evaluation of Pulmonary Embolism and Thrombolysis in patients admitted to the Intensive Care Unit (REPEAT ICU) 

    4. Alison Bentley (Island Health)

    • Counting the Carbon: Quantifying Financial and Environmental Implications of Wasted Inhaler Doses in the Hospital Setting 

    5. Franklin Hu (Lower Mainland Pharmacy Services)

    • Patient-reported Outcomes and Experience following Initiation of Elexacaftor/Tezacaftor/Ivacaftor for the Treatment of Cystic Fibrosis 

    Alberta Branch (1 award)

    6. Christina Watts (Alberta Health Services)

    • Pharmacist Telephone Follow-up for Antineoplastic Agents used in Hematologic Cancers 

    Saskatchewan Branch (1 award)
    7. Calvin Yee and Habiba Elshorbagy (Saskatchewan Health Authority)

    • Entrust the Process: Development and Implementation of an Entrustable Professional Activity Assessment Tool for Pharmacy Students Educating Patients on Oral Anticoagulant 

    Manitoba Branch (1 award)
    8. Danielle D'Entremont  (Winnipeg Regional Health Authority)

    • Characterizing Empiric Antibiotic Therapy for Pediatric Cellulitis at a Hospital with a High Prevalence of MRSA 

    New Brunswick and Nova Scotia Branches (1 award)
    9. Austin Harding (Nova Scotia Health Authority)

    • Identifying Influences on Decision-Making Regarding Antipsychotic Prescribing to Long-Term Care Residents with Dementia: A Systematic Review of Qualitative Literature

    Newfoundland and Labrador Branch (1 award)
    10. Courtney Donovan (Newfoundland and Labrador Health Services)

    • A quality-of-life assessment and personal recount of patients currently receiving Cystic Fibrosis therapy with elexacaftor/tezacaftor/ivacaftor 

    Ontario Branch (4 awards)
    11. Sarah Tessier (The Ottawa Hospital)

    • Assessing Hospital Pharmacists’ Clinical Scope of Practice in Ontario 

    12. Spencer Candy (The Ottawa Hospital)

    • Prospective Comparison of Vancomycin Area Under the Curve and Trough Concentration in Specific Populations 

    13. Gabrielle Busque (Unity Health Toronto)

    • Describing and Evaluating the Clinical Pharmacist's Role in a Canadian Multiple Sclerosis Clinic

    14.  Mishka Danchuk-Lauzon (Sunnybrook Health Sciences Centre)

    • Cannabis Prevalence and Patterns of Use in Cancer Patients Receiving Systemic Anticancer Treatment at Sunnybrook Odette Cancer Centre: A Prospective Survey Study